Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F Watts

Showing results (531-540 of 706) with videos related to

Pageof 71
Sort By:
American Journal of Preventive Cardiology|June 15, 2026
Screening for high coronary plaque volume in primary prevention: integration of multi-omics and coronary calcium scoring into cardiovascular risk assessmentCheng Hwee Soh, Shaun Khanna, Jingqin Wu, et al.
Bone|April 21, 2025
The effect of oral colchicine and vitamin K1 on bone metabolism in patients with diabetes mellitus: A post-hoc analysis of a 2 × 2 factorial randomized controlled trial with <sup>18</sup>F-sodium fluoride positron emission tomographyJamie W Bellinge, Marc Sim, Roslyn J Francis, et al.
Heart, Lung & Circulation|January 10, 2017
A Web-Based Registry for Familial HypercholesterolaemiaKathryn R Napier, Jing Pang, Leanne Lamont, et al.
The Clinical Biochemist. Reviews|February 25, 2012
A model of care for familial hypercholesterolaemia: key role for clinical biochemistryGerald F Watts, David R Sullivan, Frank M van Bockxmeer, et al.
JAMA|April 8, 2024
Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a): A Randomized Clinical TrialSteven E Nissen, Kathy Wolski, Gerald F Watts, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 28, 2025
Triglyceride to High-Density Lipoprotein Cholesterol Ratio as a Marker of Subclinical Coronary Atherosclerosis and Hepatic Steatosis in Familial HypercholesterolemiaGavin Huangfu, Dick C Chan, Jing Pang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 31, 2015
Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitusEsther M Ooi, Gerald F Watts, Dick C Chan, et al.
Journal of Clinical Apheresis|September 10, 2020
Lipoprotein apheresis and PCSK9 inhibitors for severe familial hypercholesterolaemia: Experience from Australia and New ZealandMichael M Page, Elif I Ekinci, John R Burnett, et al.
Cardiology|February 9, 2023
Lipoprotein(a) Is Associated with Thrombus Burden in Culprit Arteries of Younger Patients with ST-Segment Elevation Myocardial InfarctionDipen M Sankhesara, Nick S R Lan, Poppy Gilfillan, et al.
BMJ Open|March 3, 2025
Family planning, pregnancy, and breastfeeding care in familial hypercholesterolaemia: a study protocol for a mixed-methods study in the Netherlands, Norway and Australia (Taking ACTion to Improve Care of coupleS in FH (TACTICS))Janneke W C M Mulder, Jing Pang, Marianne Klevmoen, et al.
Pageof 71

Showing results (531-540 of 706) with videos related to

Sort By:
Pageof 71
American Journal of Preventive Cardiology|June 15, 2026
Screening for high coronary plaque volume in primary prevention: integration of multi-omics and coronary calcium scoring into cardiovascular risk assessmentCheng Hwee Soh, Shaun Khanna, Jingqin Wu, et al.
Bone|April 21, 2025
The effect of oral colchicine and vitamin K1 on bone metabolism in patients with diabetes mellitus: A post-hoc analysis of a 2 × 2 factorial randomized controlled trial with <sup>18</sup>F-sodium fluoride positron emission tomographyJamie W Bellinge, Marc Sim, Roslyn J Francis, et al.
Heart, Lung & Circulation|January 10, 2017
A Web-Based Registry for Familial HypercholesterolaemiaKathryn R Napier, Jing Pang, Leanne Lamont, et al.
The Clinical Biochemist. Reviews|February 25, 2012
A model of care for familial hypercholesterolaemia: key role for clinical biochemistryGerald F Watts, David R Sullivan, Frank M van Bockxmeer, et al.
JAMA|April 8, 2024
Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a): A Randomized Clinical TrialSteven E Nissen, Kathy Wolski, Gerald F Watts, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 28, 2025
Triglyceride to High-Density Lipoprotein Cholesterol Ratio as a Marker of Subclinical Coronary Atherosclerosis and Hepatic Steatosis in Familial HypercholesterolemiaGavin Huangfu, Dick C Chan, Jing Pang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 31, 2015
Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitusEsther M Ooi, Gerald F Watts, Dick C Chan, et al.
Journal of Clinical Apheresis|September 10, 2020
Lipoprotein apheresis and PCSK9 inhibitors for severe familial hypercholesterolaemia: Experience from Australia and New ZealandMichael M Page, Elif I Ekinci, John R Burnett, et al.
Cardiology|February 9, 2023
Lipoprotein(a) Is Associated with Thrombus Burden in Culprit Arteries of Younger Patients with ST-Segment Elevation Myocardial InfarctionDipen M Sankhesara, Nick S R Lan, Poppy Gilfillan, et al.
BMJ Open|March 3, 2025
Family planning, pregnancy, and breastfeeding care in familial hypercholesterolaemia: a study protocol for a mixed-methods study in the Netherlands, Norway and Australia (Taking ACTion to Improve Care of coupleS in FH (TACTICS))Janneke W C M Mulder, Jing Pang, Marianne Klevmoen, et al.
Pageof 71